Lemaitre Vascular (LMAT) Operating Leases (2019 - 2026)

Lemaitre Vascular (LMAT) has 8 years of Operating Leases data on file, last reported at $20.9 million in Q1 2026.

• Quarterly Operating Leases rose 42.1% year-over-year to $20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.9 million (up 42.1% YoY) and the FY2025 annual result came in at $14.0 million, down 8.07% from the prior year.
• Operating Leases improved to $20.9 million in Q1 2026 per LMAT's latest filing, from $14.0 million in the prior quarter.
• Across five years, Operating Leases topped out at $20.9 million in Q1 2026 and bottomed at $14.0 million in Q4 2025.
• The 5-year median for Operating Leases is $15.4 million (2022), against an average of $16.0 million.
• The widest annual swing landed in 2025, when Operating Leases declined 21.93%; it then soared 42.1% in 2026.
• Tracing LMAT's Operating Leases over 5 years: stood at $14.7 million in 2022, then rose by 13.01% to $16.6 million in 2023, then slipped by 8.37% to $15.2 million in 2024, then dropped by 8.07% to $14.0 million in 2025, then surged by 49.6% to $20.9 million in 2026.
• Per Business Quant, the three latest LMAT Operating Leases figures stand at $20.9 million (Q1 2026), $14.0 million (Q4 2025), and $14.4 million (Q3 2025).

Peer Comparison